Sign up to get free evidence-based articles, exclusive discounts, and insights from industry-leaders.
Email could not be subscribed.
Thank you for signing up!
presented by Nicole L. Stout, DPT, CLT-LANA, FAPTA
Financial: Nicole Stout receives compensation from Survivorship Solutions, LLC, and is an SME consultant. She also receives compensation from MedBridge for this course.
Nonfinancial: Nicole Stout is a member of the WHO Development Group on the Package of Essential Interventions in Cancer Rehabilitation. She is also a steering committee member of the Exercise is Medicine™ Moving Through Cancer Task Force.
Satisfactory completion requirements: All disciplines must complete learning assessments to be awarded credit, no minimum score required unless otherwise specified within the course.
MedBridge is committed to accessibility for all of our subscribers. If you are in need of a disability-related accommodation, please contact [email protected]. We will process requests for reasonable accommodation and will provide reasonable accommodations where appropriate, in a prompt and efficient manner.
Nicole L. Stout, DPT, CLT-LANA, FAPTA
Dr. Nicole L. Stout is a research assistant professor in the School of Medicine, Department of Hematology/Oncology at West Virginia University Cancer Institute and with the School of Public Health, Department of Health Policy, Management, and Leadership. She also serves as the associate director of the WVU Cancer Institute's Survivorship Program, where she coordinates the…
Read full bioEmail could not be subscribed.
Thank you for signing up!
Thank you!
1. Cancer Treatment Late Effects
Late effects of cancer treatments occur months or years after cancer treatments are completed and can negatively impact various body systems. Late effects contribute to loss of function as an individual ages and may magnify age-related functional changes. This chapter covers common late effects of past cancer treatments, treatment toxicities, and consideration for adaptations to the rehabilitation plan of care.
2. Managing Late Effects Alongside Age-Related Comorbidities
Older adults have unique needs after cancer treatment and throughout the remaining lifespan. Aging introduces multisystem changes, comorbidities, and pharmacologic interventions that can be influenced by the late effects of cancer treatments. This chapter covers common age-related morbidity, how it is influenced by cancer treatments, and evidence-based interventions.
3. Cancer Recurrence and Progressive Disease in Older Adults
Cancer that was treated in the past may recur and become progressive over time. Recurrence of disease introduces new and often novel anticancer treatments that negatively influence function in older adults. This chapter covers common patterns of disease recurrence and special considerations for rehabilitation interventions with advanced or progressive disease, including mobility restrictions with bone disease, critical thresholds of blood markers, and cognitive adaptations with brain and central nervous system involvement.
More Courses in this Series
Email could not be subscribed.
Thank you for signing up!
For larger groups (25+ seats), request a demo to learn more about solution options and pricing for your organization. For detailed pricing and self-service check-out, visit Plans & Pricing.
Fill out the form below to learn about our solution and pricing for your organization. For other questions or support, visit our contact page.
Fill out the form below to learn about our solution and pricing for your organization. For other questions or support, visit our contact page.